Literature DB >> 20959505

Metal emissions and urban incident Parkinson disease: a community health study of Medicare beneficiaries by using geographic information systems.

Allison W Willis1, Bradley A Evanoff, Min Lian, Aiden Galarza, Andrew Wegrzyn, Mario Schootman, Brad A Racette.   

Abstract

Parkinson disease associated with farming and exposure to agricultural chemicals has been reported in numerous studies; little is known about Parkinson disease risk factors for those living in urban areas. The authors investigated the relation between copper, lead, or manganese emissions and Parkinson disease incidence in the urban United States, studying 29 million Medicare beneficiaries in the year 2003. Parkinson disease incidence was determined by using beneficiaries who had not changed residence since 1995. Over 35,000 nonmobile incident Parkinson disease cases, diagnosed by a neurologist, were identified for analysis. Age-, race-, and sex-standardized Parkinson disease incidence was compared between counties with high cumulative industrial release of copper, manganese, or lead (as reported to the Environmental Protection Agency) and counties with no/low reported release of all 3 metals. Parkinson disease incidence (per 100,000) in counties with no/low copper/lead/manganese release was 274.0 (95% confidence interval (CI): 226.8, 353.5). Incidence was greater in counties with high manganese release: 489.4 (95% CI: 368.3, 689.5) (relative risk = 1.78, 95% CI: 1.54, 2.07) and counties with high copper release: 304.2 (95% CI: 276.0, 336.8) (relative risk = 1.1, 95% CI: 0.94, 1.31). Urban Parkinson disease incidence is greater in counties with high reported industrial release of copper or manganese. Environmental exposure to metals may be a risk factor for Parkinson disease in urban areas.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20959505      PMCID: PMC2998201          DOI: 10.1093/aje/kwq303

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  28 in total

1.  Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson's disease.

Authors:  J M Gorell; C C Johnson; B A Rybicki; E L Peterson; G X Kortsha; G G Brown; R J Richardson
Journal:  Neurotoxicology       Date:  1999 Apr-Jun       Impact factor: 4.294

2.  Manganese poisoning in Moroccan miners.

Authors:  J RODIER
Journal:  Br J Ind Med       Date:  1955-01

3.  Pesticide exposure and self-reported Parkinson's disease in the agricultural health study.

Authors:  F Kamel; Cm Tanner; Dm Umbach; Ja Hoppin; McR Alavanja; A Blair; K Comyns; Sm Goldman; M Korell; Jw Langston; Gw Ross; Dp Sandler
Journal:  Am J Epidemiol       Date:  2006-11-20       Impact factor: 4.897

4.  The presymptomatic period in a patient with idiopathic parkinsonism.

Authors:  H Shinotoh; F J Vingerhoets; M Schulzer; B J Snow
Journal:  Parkinsonism Relat Disord       Date:  1996-07       Impact factor: 4.891

5.  Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure.

Authors:  V N Uversky; J Li; A L Fink
Journal:  J Biol Chem       Date:  2001-09-11       Impact factor: 5.157

6.  Occupation and parkinsonism in three movement disorders clinics.

Authors:  S M Goldman; C M Tanner; C W Olanow; R L Watts; R D Field; J W Langston
Journal:  Neurology       Date:  2005-09-14       Impact factor: 9.910

7.  Copper, ceruloplasmin, superoxide dismutase and iron parameters in Parkinson's disease.

Authors:  G Tórsdóttir; J Kristinsson; S Sveinbjörnsdóttir; J Snaedal; T Jóhannesson
Journal:  Pharmacol Toxicol       Date:  1999-11

8.  Demographic differences in referral rates to neurologists of patients with suspected Parkinson's disease: implications for case-control study design.

Authors:  B A Rybicki; C C Johnson; J M Gorell
Journal:  Neuroepidemiology       Date:  1995       Impact factor: 3.282

9.  High prevalence of parkinsonism after occupational exposure to lead-sulfate batteries.

Authors:  W Kuhn; R Winkel; D Woitalla; S Meves; H Przuntek; T Müller
Journal:  Neurology       Date:  1998-06       Impact factor: 9.910

10.  CXCR4 and CXCL12 expression is increased in the nigro-striatal system of Parkinson's disease.

Authors:  Mika Shimoji; Fernando Pagan; Edward B Healton; Italo Mocchetti
Journal:  Neurotox Res       Date:  2009-06-24       Impact factor: 3.911

View more
  55 in total

1.  Neuromythology of Manganism.

Authors:  Kristin M Andruska; And Brad A Racette
Journal:  Curr Epidemiol Rep       Date:  2015-06

2.  The reproducibility of urinary ions in manganese exposed workers.

Authors:  Marissa G Baker; Yvonne S Lin; Christopher D Simpson; Laura M Shireman; Susan Searles Nielsen; Brad A Racette; Noah Seixas
Journal:  J Trace Elem Med Biol       Date:  2018-11-03       Impact factor: 3.849

3.  Effects of parkinsonism on health status in welding exposed workers.

Authors:  Rachel C Harris; Jessica I Lundin; Susan R Criswell; Angela Hobson; Laura M Swisher; Bradley A Evanoff; Harvey Checkoway; Brad A Racette
Journal:  Parkinsonism Relat Disord       Date:  2011-07-02       Impact factor: 4.891

4.  Inducible nitric oxide synthase gene methylation and parkinsonism in manganese-exposed welders.

Authors:  Susan Searles Nielsen; Harvey Checkoway; Susan R Criswell; Federico M Farin; Patricia L Stapleton; Lianne Sheppard; Brad A Racette
Journal:  Parkinsonism Relat Disord       Date:  2015-01-17       Impact factor: 4.891

5.  PARK2 patient neuroprogenitors show increased mitochondrial sensitivity to copper.

Authors:  Asad A Aboud; Andrew M Tidball; Kevin K Kumar; M Diana Neely; Bingying Han; Kevin C Ess; Charles C Hong; Keith M Erikson; Peter Hedera; Aaron B Bowman
Journal:  Neurobiol Dis       Date:  2014-10-12       Impact factor: 5.996

Review 6.  Molecular and Clinical Aspects of Protein Aggregation Assays in Neurodegenerative Diseases.

Authors:  Anna Villar-Piqué; Matthias Schmitz; Niccolò Candelise; Salvador Ventura; Franc Llorens; Inga Zerr
Journal:  Mol Neurobiol       Date:  2018-02-10       Impact factor: 5.590

7.  Predictors of survival in patients with Parkinson disease.

Authors:  Allison W Willis; Mario Schootman; Nathan Kung; Bradley A Evanoff; Joel S Perlmutter; Brad A Racette
Journal:  Arch Neurol       Date:  2012-05

Review 8.  An update on the diagnosis and treatment of Parkinson disease.

Authors:  Philippe Rizek; Niraj Kumar; Mandar S Jog
Journal:  CMAJ       Date:  2016-05-24       Impact factor: 8.262

9.  Bioaccessibility of metals in alloys: evaluation of three surrogate biofluids.

Authors:  Wendy E Hillwalker; Kim A Anderson
Journal:  Environ Pollut       Date:  2013-11-08       Impact factor: 8.071

Review 10.  Associations of welding and manganese exposure with Parkinson disease: review and meta-analysis.

Authors:  James A Mortimer; Amy R Borenstein; Lorene M Nelson
Journal:  Neurology       Date:  2012-09-11       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.